Breast Medical Oncologist @clevelandclinic Taussig Can Inst. | Interested in experimental therapeutics #bcsm | @hemeoncgators and @MUSC_COM alum. Views = me
Cleveland, OH
Joined March 2013
- Tweets185
- Following197
- Followers363
- Likes625
Azka Ali, MD retweeted
Use of Vaginal Estrogen in Breast and Gynecologic Cancer Survivors. Co-authored by @AzkaAliMD.
Read the full article. bit.ly/4rSrcCx
#BreastCancer #bcsm #gyncsm
Azka Ali, MD retweeted
Use of Vaginal Estrogen in Breast and Gynecologic Cancer Survivors
Great review👇
ascopubs.org/doi/10.1200/OP-…
Azka Ali, MD retweeted
Use of Vaginal Estrogen in Breast and Gynecologic Cancer Survivors | JCO Oncology Practice ascopubs.org/doi/10.1200/OP-… @OncoAlert @JCOOP_ASCO @MMAlHilli @ClevelandClinic in selected patients with refractory symptoms low dose vaginal estrogen could be effective !
Azka Ali, MD retweeted
Biology continues to be more complicated than stage.
🔵Real-world HR+/HER2− early #BreastCancer (Flatiron EHR, n=7,481; 78-mo FU).
N0 with high-risk features had recurrence & mortality risk comparable to N1, indicating meaningful risk beyond nodal status.
🖋️@PTarantinoMD @DrSGraff
🔗 oxford.ly/4vMKrgV
Azka Ali, MD retweeted
Check out our @JACCJournals editorial (jacc.org/doi/10.1016/j.jacc.…) on the FOURIER Prespecified Analysis showing obesity-associated benefit from PCSK9i, evolocumab (jacc.org/doi/10.1016/j.jacc.…). @CBallantyneMD @arsalanhamid93 @vijay_nambi @hwubcm
Azka Ali, MD retweeted
Dr. @AzkaAliMD (@ClevelandClinic) shares how CNN-based AI models (e.g., IbRiS) applied to H&E slides predict DFS/OS in ER+ breast cancer; retrospectively validated across U.S. & India cohorts. Outperforms Oncotype in ILC & Black pts. Scalable, low-cost risk tool. #DAVABreast
Azka Ali, MD retweeted
USP1 regulates replication fork stability. Dr. @AzkaAliMD (@ClevelandClinic) highlights KSQi (RO7623066) as a USP1i that synergizes with Olaparib. Tumor regressions seen in BRCA1+ mBC; PK and biomarker data support continued study. #DAVABreast
Azka Ali, MD retweeted
Dr. Shreya Sengupta was a gifted clinician, rising health services researcher, and fierce advocate for the most vulnerable. Her work transformed ALD care and advanced equity in hepatology.
Thank you @AASLDtweets for honoring her legacy. Donate: aasld.org/shreya-sengupta-md
Azka Ali, MD retweeted
It's been exactly 20 years since my first day of internship
As I reflect on my disproportionate aging since then (gray hairs >>> wisdom), here are my 10 unsolicited recommendations for any colleague embarking on residency
THE "ATTENDING ADVICE YOU DIDN'T ASK FOR" THREAD ...
Azka Ali, MD retweeted
9th Annual Cleveland Breast Cancer Summit: Collaborating for a Cure- Friday August 8, 2025. Triple Negative Breast Cancer
clevelandclinicmeded.com/liv…
Azka Ali, MD retweeted
Slideshow: ADCs like #DatoDXd and next-gen endocrine therapies offer new options—but with more choice comes tougher clinical questions. bit.ly/3Z5qBjM #BreastCancer #Oncology #ADCs #EndocrineTherapy @jhaveri_komal @ErinCobain @AzkaAliMD @dradityabardia @jrgralow
Azka Ali, MD retweeted
Wonderful to see @ThejusJay featured in @DFarberYoungCRC ! @ccfhemonc @ClevelandClinic @CleClinicMD Alumni!
Today’s Specialist Spotlight is @ThejusJay Dr. Jayakrishnan is a Medical Oncologist at DFCI treating patients with all types of GI cancers and focuses his research on critical gaps in the understanding of early-onset GI cancers through translational research. Welcome to the team!
Azka Ali, MD retweeted
KEYNOTE-522: Exploratory #Biomarker analysis highlights TMB & T-cell-inflamed GEP as linked to better outcomes in early-stage #TripleNegativeBreastCancer. #Pembrolizumab shows efficacy across biomarker-defined subgroups.
bit.ly/41Vka55 @AzkaAliMD #SABCS24 #TNBC
Azka Ali, MD retweeted
Wonderful to see @ClevelandClinic along with other major cancer centers !
Here are the Top 10 Most Active Cancer Institutes that are leading the conversation in innovation and insights, ranked based on oncologists' reactions and engagement on X (formerly Twitter).
#LARVOL #CancerResearch #Oncology #OncologyInsights #CancerData
Azka Ali, MD retweeted
Advances in early breast cancer from #SABCS24. With @AzkaAliMD and @Haddad_Sara7 of @ClevelandClinic, @MOliveira_MD of @vallhebron, Dr Toralf Reimer of @unirostock, @gandhi_shipra of @RoswellPark, and Dr Sheldon Feldman of @MontefioreNYC. #bcsm cancertherapyadvisor.com/ind…
Azka Ali, MD retweeted
Tune in to the latest @CleClinicMD Cancer Advances podcast! @AzkaAliMD shares insights from #SABCS24 on ESR1 mutations, PI3K pathways, and advancing treatments for HR+/HER2- #breastcancer #CleClinicCancer cle.clinic/4gkO8DN
Azka Ali, MD retweeted
Thanks so much to @AzkaAliMD, of @clevelandclinic, for sitting down with us at #SABCS24 to speak about alternative chemo dosing schedules in breast cancer! Check out our site for insights from Dr Ali and more! @SABCSSanAntonio #bcsm #oncology
onclive.com/conference/sabcs
Azka Ali, MD retweeted
Congratulations to @AzkaAliMD for presenting @SWOG S0221 long term follow up data @SABCSSanAntonio #sabcs24 @OncoAlert @oncodaily @gt_budd @CleClinicMD
Azka Ali, MD retweeted
Congratulations to @HundalJasmin for her poster presentation at @SABCSSanAntonio #sabcs24 @ClevelandClinic @ccfhemonc !
